Cargando…

Low serum PSA levels of diabetes mellitus-caused end-stage renal disease patients

Detalles Bibliográficos
Autores principales:	Wada, Yoshihiro, Kikuchi, Ken, Kikukawa, Hiroaki, Imamura, Takahisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2008
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375228/ https://www.ncbi.nlm.nih.gov/pubmed/30792791 http://dx.doi.org/10.1093/ndtplus/sfm001

Ejemplares similares

Diabetes mellitus as a cause of end-stage renal disease in Europe: signs of improvement
por: van den Brand, Jan A.J.G.
Publicado: (2016)

Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection
por: Höti, Naseruddin, et al.
Publicado: (2023)

Serum transferrin predicts end-stage Renal Disease in Type 2 Diabetes Mellitus patients
por: Zhao, Lijun, et al.
Publicado: (2020)

Glucose Serum Concentrations and Cardiovascular Disease in Patients on the End Stage of Renal Disease without Diabetes Mellitus
por: Raikou, Vaia D., et al.
Publicado: (2015)

Clinical significance of serum PSA in breast cancer patients
por: Hanamura, Toru, et al.
Publicado: (2019)

Fasting times in serum PSA assay
por: Xu, Xiang, et al.
Publicado: (2014)

The Relationship between Prostate Biopsy Results and PSA and Free PSA Ratio Changes in Elevated Serum PSA Patients with and without Antibiotherapy
por: Duran, Mesut Berkan, et al.
Publicado: (2020)

Oxidized Low-Density Lipoprotein Serum Concentrations and Cardiovascular Morbidity in End Stage of Renal Disease †
por: Raikou, Vaia, et al.
Publicado: (2018)

Serum Endocannabinoid Levels in Patients With End-Stage Renal Disease
por: Moradi, Hamid, et al.
Publicado: (2019)

Association between Low Serum Bicarbonate Concentrations and Cardiovascular Disease in Patients in the End-Stage of Renal Disease
por: Raikou, Vaia D., et al.
Publicado: (2016)

Establishment of reference intervals for serum [−2]proPSA (p2PSA), %p2PSA and prostate health index in healthy men
por: Wu, Zhi-Yu, et al.
Publicado: (2019)

Re: Fasting times in serum PSA assay
por: Lau, Cheryl K, et al.
Publicado: (2014)

Is serum PSA a predictor of male hypogonadism?
Publicado: (2021)

The Impact of Diabetes Mellitus on Vascular Biomarkers in Patients with End-Stage Renal Disease
por: Moon, Jeonggeun, et al.
Publicado: (2017)

Cause of postoperative mortality in patients with end-stage renal disease
por: Song, Sanghoon, et al.
Publicado: (2022)

Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer
por: Lehrer, S, et al.
Publicado: (2002)

Association of Polymorphisms in the Prostate-Specific Antigen (PSA) Gene Promoter with Serum PSA Level and PSA Changes after Dutasteride Treatment in Korean Men with Benign Prostatic Hypertrophy
por: Park, Sung Woon, et al.
Publicado: (2010)

Serum Concentration of Cystatin C and Risk of End-Stage Renal Disease in Diabetes
por: Krolewski, Andrzej S., et al.
Publicado: (2012)

Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis
por: Matsuda, Shogo, et al.
Publicado: (2023)

Temperature Control of psaA Expression by PsaE and PsaF in Yersinia pestis
por: Quinn, Joshua D., et al.
Publicado: (2019)

Low income, community poverty and risk of end stage renal disease
por: Crews, Deidra C, et al.
Publicado: (2014)

Severe bleeding tendency caused by a rare complication of excessive fibrinolysis with disseminated intravascular coagulation in a 51-year-old Japanese man with prostate cancer: a case report
por: Wada, Yoshihiro, et al.
Publicado: (2012)

T-Cell Cytokine Gene Polymorphisms and Vitamin D Pathway Gene Polymorphisms in End-Stage Renal Disease due to Type 2 Diabetes Mellitus Nephropathy: Comparisons with Health Status and Other Main Causes of End-Stage Renal Disease
por: Grzegorzewska, Alicja E., et al.
Publicado: (2014)

The Role of Serum Magnesium and Calcium on the Association between Adiponectin Levels and All-Cause Mortality in End-Stage Renal Disease Patients
por: Markaki, Anastasia, et al.
Publicado: (2012)

Impact of Diabetes Mellitus on the Risk of End-Stage Renal Disease in Patients with Systemic Lupus Erythematosus
por: Jiang, Ming-Yan, et al.
Publicado: (2018)

Vitamin D Deficiency in End Stage Renal Disease Patients with Diabetes Mellitus Undergoing Hemodialysis
por: Ali, Muhammad, et al.
Publicado: (2020)

Androgen dynamics and serum PSA in patients treated with abiraterone acetate
por: Ryan, C J, et al.
Publicado: (2014)

Is serum PSA a predictor of male hypogonadism? Testing the hypothesis
por: Amadi, Collins, et al.
Publicado: (2021)

End stage renal disease caused by thromboangiitis obliterans: a case report
por: Yun, Hyo-Jin, et al.
Publicado: (2015)

Bardet–Biedl syndrome: A rare cause of end stage renal disease
por: Hemachandar, R
Publicado: (2015)

Unicentric Castleman’s disease associated with end stage renal disease caused by amyloidosis
por: Eroglu, Eray, et al.
Publicado: (2017)

Association of serum prostate-specific antigen (PSA) level and circulating tumor cell-based PSA mRNA in prostate cancer
por: Cho, Hyungseok, et al.
Publicado: (2022)

Serum albumin and mortality in patients with HIV and end-stage renal failure on peritoneal dialysis
por: Ndlovu, Kwazi Celani Zwakele, et al.
Publicado: (2019)

Correlations between serum inflammatory markers and comorbidities in patients with end-stage renal disease
por: Eloueyk, Asmahan K., et al.
Publicado: (2019)

Serum metabolomics of end-stage renal disease patients with depression: potential biomarkers for diagnosis
por: Yuan, Dezhi, et al.
Publicado: (2021)

End Stage Renal Disease and Medicare
por: Greer, Joel W.
Publicado: (2003)

Association between atrial fibrillation and risk of end-stage renal disease among adults with diabetes mellitus
por: Chang, Yu-Kang, et al.
Publicado: (2022)

Significance of Serum Testosterone for Prostate-Specific Antigen (PSA) Elevation and Prediction of Prostate Cancer in Patients with PSA Above 10 ng/ml
por: Koo, Jin Mo, et al.
Publicado: (2010)

Contribution of allelic variability in prostate specific antigen (PSA) & androgen receptor (AR) genes to serum PSA levels in men with prostate cancer
por: Chavan, Sushant V., et al.
Publicado: (2014)

Impaired plasma clottability induction through fibrinogen degradation by ASP, a serine protease released from Aeromonas sobria
por: Imamura, Takahisa, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_oflmludh8m166kk9g583ar3ju2